REGEN BIOPHARMA, INC. Deferred Tax Assets, Gross
REGEN BIOPHARMA, INC. (RGBP) had Deferred Tax Assets, Gross of $4.68 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-08-17
- 2026-06-30: Deferred Tax Assets, Gross $4.68M.
- 2026-03-31: Deferred Tax Assets, Gross $4.55M.
- 2025-12-31: Deferred Tax Assets, Gross $4.76M.
- 2025-09-30: Deferred Tax Assets, Gross $4.56M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2026-06-30 | $4.68M 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $4.55M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $4.76M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $4.56M 10-Q · filed 2026-08-17 | |
| 2024-09-30 | $4.29M 10-K · filed 2025-12-30 | $4.33M 8-K · filed 2024-11-29 |
| 2023-09-30 | $4.15M 10-K · filed 2025-05-13 | |
| 2022-09-30 | $4.39M 10-K · filed 2022-11-15 | |
| 2021-09-30 | $4.90M 10-K · filed 2021-12-22 | |
| 2020-09-30 | $3.48M 10-K · filed 2021-08-04 | |
| 2019-09-30 | $4.20M 10-K · filed 2021-06-21 | |
| 2018-12-31 | $3.60M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $3.67M 10-K · filed 2018-12-27 | |
| 2018-06-30 | $3.46M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $3.50M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $5.28M 10-Q · filed 2018-02-06 | |
| 2017-09-30 | $4.33M 10-K · filed 2018-01-05 | |
| 2017-06-30 | $3.91M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $3.02M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $7.73M 10-Q/A · filed 2017-04-28 | |
| 2016-09-30 | $6.88M 10-K/A · filed 2017-04-28 | |
| 2016-06-30 | $6.04M 10-Q/A · filed 2017-04-28 | |
| 2016-03-31 | $5.24M 10-Q/A · filed 2017-04-28 | |
| 2015-12-31 | $4.87M 10-Q/A · filed 2017-04-28 | |
| 2015-09-30 | $4.24M 10-K/A · filed 2017-04-28 | |
| 2015-06-30 | $4.04M 10-Q/A · filed 2017-04-28 | |
| 2015-03-31 | $3.51M 10-Q/A · filed 2017-04-28 | |
| 2014-12-31 | $509.24K 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $434.72K 10-K · filed 2014-12-18 | |
| 2014-06-30 | $368.55K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $312.10K 10-Q · filed 2014-05-05 |